共 50 条
- [41] How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis) CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (11): : E826 - E831
- [42] Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis Nature Communications, 10
- [44] Venetoclax in Immunoglobulin Light Chain Amyloidosis: Is This the Beginning or the End? CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : 686 - 688
- [45] Treatment Tolerability in Patients with Immunoglobulin Light Chain Amyloidosis AMERICAN HEALTH AND DRUG BENEFITS, 2018, 11 (08): : 430 - 437
- [50] Immunoglobulin Light Chain Amyloidosis: Diagnosis and Risk Assessment JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (01): : 83 - 90